Previous close | 99.00 |
Open | 98.00 |
Bid | 192.00 |
Ask | 201.00 |
Strike | 150.00 |
Expiry date | 2024-01-19 |
Day's range | 98.00 - 99.00 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Align Technology, Inc. ( NASDAQ:ALGN ) shareholders (or potential shareholders) will be happy to see that the...
TEMPE, Ariz., May 24, 2023--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's we
Let's face it: 2023 has been all about the growth stocks. If you need proof, compare the year-to-date performances of the Vanguard Growth ETF and the Vanguard Value ETF. With that in mind, let's have a look at three growth stocks that have been doing well in the near term that are also long-term buy-and-hold candidates: CrowdStrike Holdings (NASDAQ: CRWD), Align Technology (NASDAQ: ALGN), and Nvidia (NASDAQ: NVDA).
When a business is making headway in a massive and uncontested global market, shareholders reap the benefits. The result could well be a run of wild growth over the next few years. Align Technology's (NASDAQ: ALGN) business model is simple: It sells its Invisalign tooth straighteners to dentists and orthodontists, who use its scanning and 3D modeling devices to adapt the straighteners to fit their patients -- thus eliminating the need to get traditional braces.
Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
TEMPE, Ariz., May 03, 2023--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following upcoming financial conference. The presentation, as noted below, will be webcast live via the Investor Relations section of Align Tec
Here is how AmerisourceBergen (ABC) and Align Technology (ALGN) have performed compared to their sector so far this year.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Align Technology fair value estimate is US$259 Align...
Shares of Align Technology (NASDAQ: ALGN) were down more than 10% late Thursday afternoon after the healthcare company announced first-quarter earnings. Invisalign teeth aligners have the advantage of being more comfortable and discreet compared to traditional metal braces. It was also the second consecutive quarter that the company had better numbers sequentially.
Align Technology (ALGN) delivers better-than-expected revenues and earnings in the first quarter of 2023 but suffers significant foreign currency woes.
Investors remained on uncertain footing on Wednesday, with major stock market benchmarks finishing the day sharply mixed. The Nasdaq Composite (NASDAQINDEX: ^IXIC) held up quite well, powered upward by strong earnings on Tuesday night from key tech giants. Meta Platforms (NASDAQ: META) saw its stock soar after offering reassuring signs that the social media pioneer will continue to be diligent in controlling its costs.
Align Technology (ALGN) delivered earnings and revenue surprises of 7.69% and 3.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
TEMPE, Ariz., April 26, 2023--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'23"). Q1'23 total revenues were $943.1 million, up 4.6% sequentially and down 3.1% year-over-year. Q1'23 Clear Aligner revenues were $789.8 mil
MedTech companies' results are likely to reflect a sequential decline. Let's see how BSX, TMO, EW and ALGN fare this time.
STERIS' (STE) fourth-quarter fiscal 2023 results are likely to reflect an impressive performance across the Healthcare and AST segments, with a gradual improvement in the supply chain.
Align Technology (ALGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Instead, it's a good idea to go with a couple of must-buy, time-tested businesses that aren't about to have their share prices crash overnight. Align Technology (NASDAQ: ALGN) has a simple yet consistently successful business model that makes it a must-own stock. It develops the Invisalign series of transparent tooth straighteners that people all over the world use instead of older (and significantly less comfortable) tooth straightening devices like braces.
Bio-Rad Laboratories' (BIO) first-quarter 2023 results are likely to reflect an impressive performance across its Life Science segment, with a gradual reduction in backlogs and an improvement in the supply chain.
General Electric, Kimberly-Clark, Corning, Raytheon Technologies and Align Technology are included in this Analyst Blog.
TEMPE, Ariz. & SAN FRANCISCO, April 21, 2023--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology has been honored as a "Technology Partner of the Year" by Junior Achievement of Northern California (JA NorCal) at the Junior Achievement of Northern
IDEXX Laboratories' (IDXX) first-quarter 2023 results are expected to reflect an impressive performance in the CAG segment despite inflationary impacts.
We have narrowed our search to five U.S. corporate bigwigs that are set to report first-quarter 2023 earnings results next week. These are: GE, KMB, GLW, RTX and ALGN.
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Quest Diagnostics' (DGX) first-quarter 2023 results are likely to reflect an impressive performance in its non-COVID-19 base business amid inflationary pressure and labor challenges.
Align Technology (ALGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.